bit.bio launches Huntington’s disease human cell model
First neurodegenerative disease model launched from bit.bio's new ioDisease Model portfolio.
First neurodegenerative disease model launched from bit.bio's new ioDisease Model portfolio.
Trestle gains access to pioneering kidney stem cell biology differentiation protocols
New SureSeq™ FFPE DNA Repair Mix delivers excellent sequencing data for confident variant calling from minimal DNA input
Horizon’s X-MAN cell lines to be made available in conjunction with Ubiquigent’s ubiquitin-related Drug Discovery Services
Watch this on-demand webinar to learn about the development of a high-throughput lipidomics platform and its application in population profiling studies
The artus® SARS-CoV-2 Prep&Amp UM cuts PCR processing times by two thirds
The findings will allow manufacturers to identify whether their juices contain A. suci, which leads to spoilage
Company rapidly expanding commercial operations to enable more researchers to extract higher yields of DNA and RNA from FFPE samples in one hour with minimal hands-on time
Label individual cells with uniquely identifiable, expressed barcodes to understand how different experimental conditions affect distinct groups of cells from a common progenitor.
Discover the latest news from this conference on correlative microscopy
GATC Biotech Offers the First Global Liquid Biopsy Service for Clinical Research and Translational Medicine